QL AG, a food technology solutions company, announced a new collaboration to develop dairy proteins with Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity. QL AG will tap into Ginkgo’s extensive capabilities in strain engineering across multiple chassis organisms to support its goal of providing the market with high-quality nutritionally equivalent dairy proteins.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DNA:
- Cathie Wood’s ARK Investment bought 2.05M shares of Ginkgo Bioworks today
- Ginkgo Bioworks unit partners with Northeastern Univ. on epidemic forecasting
- Cathie Wood’s ARK Investment bought 1.43M shares of Ginkgo Bioworks today
- Ginkgo Bioworks to host investor day
- Ginkgo Bioworks, Nosh.bio announce new partnership